Search research articles
Contact Us
Filters
Showing results (1-10 of 82) with videos related to
Page
of 9
Sort By:
Blood Advances
|
September 24, 2024
Defining infection risk of bispecific antibodies for myeloma
Sarah P Hammond
Infectious Disease Clinics of North America
|
May 30, 2013
Infections in composite tissue allograft recipients
Sarah P Hammond
Journal of Oncology Practice
|
December 12, 2019
The Promise of Direct-Acting Antiviral Therapies to Improve Care and Outcomes in Patients With Cancer Who Have Chronic Hepatitis C Infection
Yiannis Koullias, Sarah P Hammond
Transplant Infectious Disease : an Official Journal of the Transplantation Society
|
May 25, 2026
Invasive Fusariosis-Time to Break the Mold
Victor Kovac, Sarah P Hammond
Current Hematologic Malignancy Reports
|
April 29, 2010
Antibiotic prophylaxis during chemotherapy-induced neutropenia for patients with acute leukemia
Sarah P Hammond, Lindsey R Baden
The New England Journal of Medicine
|
October 10, 2008
Clinical decisions. Management of skin and soft-tissue infection--polling results
Sarah P Hammond, Lindsey R Baden
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 2, 2024
The Clinical Significance of Cytomegalovirus Viremia after Chimeric Antigen Receptor T-Cell Therapy
Sarah P Hammond, Jessica S Little
Leukemia & Lymphoma
|
January 31, 2008
Antibiotic prophylaxis for patients with acute leukemia
Sarah P Hammond, Lindsey R Baden
JACC. Cardiooncology
|
April 16, 2020
The Novel Coronavirus Disease (COVID-19) Threat for Patients With Cardiovascular Disease and Cancer
Sarju Ganatra, Sarah P Hammond, Anju Nohria
Journal of Fungi (Basel, Switzerland)
|
December 24, 2021
Invasive Fungal Infections and Targeted Therapies in Hematological Malignancies
Jessica S Little, Zoe F Weiss, Sarah P Hammond
Page
of 9
Search research articles
Search
Showing results (1-10 of 82) with videos related to
Sort By:
Page
of 9
Blood Advances
|
September 24, 2024
Defining infection risk of bispecific antibodies for myeloma
Sarah P Hammond
Infectious Disease Clinics of North America
|
May 30, 2013
Infections in composite tissue allograft recipients
Sarah P Hammond
Journal of Oncology Practice
|
December 12, 2019
The Promise of Direct-Acting Antiviral Therapies to Improve Care and Outcomes in Patients With Cancer Who Have Chronic Hepatitis C Infection
Yiannis Koullias, Sarah P Hammond
Transplant Infectious Disease : an Official Journal of the Transplantation Society
|
May 25, 2026
Invasive Fusariosis-Time to Break the Mold
Victor Kovac, Sarah P Hammond
Current Hematologic Malignancy Reports
|
April 29, 2010
Antibiotic prophylaxis during chemotherapy-induced neutropenia for patients with acute leukemia
Sarah P Hammond, Lindsey R Baden
The New England Journal of Medicine
|
October 10, 2008
Clinical decisions. Management of skin and soft-tissue infection--polling results
Sarah P Hammond, Lindsey R Baden
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 2, 2024
The Clinical Significance of Cytomegalovirus Viremia after Chimeric Antigen Receptor T-Cell Therapy
Sarah P Hammond, Jessica S Little
Leukemia & Lymphoma
|
January 31, 2008
Antibiotic prophylaxis for patients with acute leukemia
Sarah P Hammond, Lindsey R Baden
JACC. Cardiooncology
|
April 16, 2020
The Novel Coronavirus Disease (COVID-19) Threat for Patients With Cardiovascular Disease and Cancer
Sarju Ganatra, Sarah P Hammond, Anju Nohria
Journal of Fungi (Basel, Switzerland)
|
December 24, 2021
Invasive Fungal Infections and Targeted Therapies in Hematological Malignancies
Jessica S Little, Zoe F Weiss, Sarah P Hammond
Page
of 9